10th December 2010

Members, Acuitas Medical, honoured at RSNA 2010 with prestigious AuntMinnie Award

Acuitas Medical honoured at RSNA 2010 with prestigious AuntMinnie Award

AuntMinnie, the radiology website portal, announced on Tuesday the results of their prestigious Minnie awards. Acuitas Medical Ltd of Swansea, Wales were nominated for the Best New Radiology Vendor by AuntMinnie.com members in September, with semifinalists and finalists selected through a vote by AuntMinnie’s expert panel of editors and radiology professionals.

These “Minnies” as they are called, recognise excellence in radiology and medical imaging and are awarded annually, just prior to the Radiological Society of North America (RSNA) meeting held each year in Chicago during the week following Thanksgiving Day. Awarded by an organisation that is a bellwether for the radiological
imaging community, these awards direct attention to nascent technologies that have the potential to set the imaging world on end.

Industry veteran of 30 years, Peter E Taylor, Acuitas Medical’s CEO and co-founder, stated: “This is truly an outstanding endorsement for our technology and the company’s vision to see our proprietary software tools deployed throughout the MRI installed base as an additional in‐workflow disease management tool. As an avid reader of AuntMinnie since its first edition this award really tops a great year for our company as we approach this year’s RSNA”.

“We are very excited by this endorsement, coming as it does from an organisation with a history of recognizing early-on paradigm-changing technologies in the diagnostic imaging community”, adds Tim James PhD, co-founder and Chief Technology Officer of Acuitas Medical.

About Acuitas Medical
Acuitas Medical Ltd., formerly known as OsteoTronix Ltd., was founded in Wales UK in 2006, to develop Fine Structure Analysis™ (fSA™), a unique application of MRI based on a discovery by Tim James, Ph.D. Dr. James theorised that structural data could be derived from MRI data at a scale much finer than possible with conventional MR imaging, and that this data could be used to diagnose and monitor the effectiveness of therapy of a wide range of diseases.

Based on Dr. James’ initial work, Acuitas Medical developed fSA, a suite of proprietary software to acquire, process and display fine structural data. Acuitas Medical has validated both theoretically and experimentally the unique capabilities of fSA and implemented it on a wide range of clinical and preclinical imaging platforms. Acuitas Medical is currently collaborating with a number of prominent research institutions to demonstrate the clinical utility of fSA in a range of diseases including interstitial lung disease, prostate disease, kidney fibrosis, osteoporosis and bone cancer. Initially focused on bone diseases, Acuitas Medical has changed its name from OsteoTronix to reflect the remarkably wide range of potential clinical applications for its unique technology.